Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2014 by The Wistar Institute
Sponsor:
Collaborators:
University of Pennsylvania
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Luis Montaner, The Wistar Institute
ClinicalTrials.gov Identifier:
NCT01935089
First received: August 27, 2013
Last updated: August 26, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)